[{"address1": "680 George Street", "address2": "Level 12", "city": "Sydney", "state": "NSW", "zip": "2000", "country": "Australia", "phone": "61 2 8280 7355", "website": "https://www.elixinolwellness.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. Elixinol Wellness Limited was incorporated in 2017 and is headquartered in Sydney, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Ronald  Dufficy BEC, FCPA", "title": "Group CEO, MD & Director", "fiscalYear": 2022, "totalPay": 276923, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Josephine  Lorenz", "title": "Global CFO & Joint Company Secretary", "fiscalYear": 2022, "totalPay": 216017, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Glen  Zurcher", "title": "Account Director of Investor Relations Department", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rob  Hasselman", "title": "President of Americas", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beata  Silber", "title": "Global Head of R&D and Innovation", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Prince ACIS, BA, GrdDipCorpGov, LLB", "title": "Joint Company Secretary", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.0134, "open": 0.0104, "dayLow": 0.0104, "dayHigh": 0.0104, "regularMarketPreviousClose": 0.0134, "regularMarketOpen": 0.0104, "regularMarketDayLow": 0.0104, "regularMarketDayHigh": 0.0104, "beta": 2.117, "volume": 1100, "regularMarketVolume": 1100, "averageVolume": 20174, "averageVolume10days": 22577, "averageDailyVolume10Day": 22577, "marketCap": 8462397, "fiftyTwoWeekLow": 0.0028, "fiftyTwoWeekHigh": 0.0197, "priceToSalesTrailing12Months": 1.0233881, "fiftyDayAverage": 0.0071054, "twoHundredDayAverage": 0.00718325, "currency": "USD", "enterpriseValue": 7134480, "profitMargins": -0.90785, "floatShares": 555943031, "sharesOutstanding": 813692032, "heldPercentInsiders": 0.061929997, "impliedSharesOutstanding": 822467008, "bookValue": 0.01, "priceToBook": 1.0400001, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -7507000, "trailingEps": -0.01, "enterpriseToRevenue": 0.863, "enterpriseToEbitda": -1.346, "52WeekChange": -0.27272725, "SandP52WeekChange": 0.30583346, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "ELLXF", "underlyingSymbol": "ELLXF", "shortName": "ELIXINOL WELLNESS LTD", "longName": "Elixinol Wellness Limited", "firstTradeDateEpochUtc": 1528205400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "6c7d575b-d8fe-33de-b8ef-217a97099876", "messageBoardId": "finmb_545070079", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.0104, "recommendationKey": "none", "totalCash": 708000, "totalCashPerShare": 0.001, "ebitda": -5301000, "totalDebt": 1262000, "quickRatio": 0.487, "currentRatio": 1.639, "totalRevenue": 8269000, "debtToEquity": 19.53, "revenuePerShare": 0.017, "returnOnAssets": -0.29261, "returnOnEquity": -0.9612, "freeCashflow": -2018375, "operatingCashflow": -2758000, "revenueGrowth": 0.254, "grossMargins": 0.41359, "ebitdaMargins": -0.64107, "operatingMargins": -0.5565, "financialCurrency": "AUD", "trailingPegRatio": null}]